Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.67 USD | +0.58% | +18.93% | +48.71% |
Apr. 19 | TScan Therapeutics Closes $150.1 Million Securities Offering | MT |
Apr. 17 | TScan Therapeutics Prices $150.1 Million Public Offering of Shares, Warrants | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.71% | 493M | |
+25.36% | 42.68B | |
-2.97% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+7.45% | 24.94B | |
-20.22% | 18.96B | |
+28.85% | 12.3B | |
-2.98% | 11.95B | |
-1.44% | 11.55B |
- Stock Market
- Equities
- TCRX Stock
- News TScan Therapeutics, Inc.
- Wedbush Adjusts TScan Therapeutics Price Target to $10 From $9, Maintains Outperform Rating